TickerFacts.

Eli Lilly & Co (LLY): Capital Expenditures

Annual figures by period end, from SEC filings.

$7.84B
Year ended 2025-12-31
+61.7%
3-year compound annual growth
+41.4%
5-year compound annual growth
+22.1%
10-year compound annual growth
2007-12-31: $1.08B2008-12-31: $947.20M2009-12-31: $765.00M2010-12-31: $694.30M2011-12-31: $672.00M2012-12-31: $905.40M2013-12-31: $1.01B2014-12-31: $1.16B2015-12-31: $1.07B2016-12-31: $1.04B2017-12-31: $1.08B2018-12-31: $1.21B2019-12-31: $1.03B2020-12-31: $1.39B2021-12-31: $1.31B2022-12-31: $1.85B2023-12-31: $3.45B2024-12-31: $5.06B2025-12-31: $7.84B$7.84B
2007-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$7.84B+55.0%2026-02-12, From 2025-01-01
2024-12-31$5.06B+46.7%2026-02-12, From 2024-01-01
2023-12-31$3.45B+85.9%2026-02-12, From 2023-01-01
2022-12-31$1.85B+41.6%2025-02-19, From 2022-01-01
2021-12-31$1.31B-5.6%2024-02-21, From 2021-01-01
2020-12-31$1.39B+34.2%2023-02-22, From 2020-01-01
2019-12-31$1.03B-14.6%2022-02-23, From 2019-01-01
2018-12-31$1.21B+12.4%2021-02-17, From 2018-01-01
2017-12-31$1.08B+3.8%2020-02-19, From 2017-01-01
2016-12-31$1.04B-2.7%2019-02-19, From 2016-01-01
2015-12-31$1.07B-8.3%2018-02-20, From 2015-01-01
2014-12-31$1.16B+14.9%2017-02-21, From 2014-01-01
2013-12-31$1.01B+11.8%2016-02-19, From 2013-01-01
2012-12-31$905.40M+34.7%2015-02-19, From 2012-01-01
2011-12-31$672.00M-3.2%2014-02-19, From 2011-01-01
2010-12-31$694.30M-9.2%2013-02-21, From 2010-01-01
2009-12-31$765.00M-19.2%2012-02-24, From 2009-01-01
2008-12-31$947.20M-12.5%2011-02-22, From 2008-01-01
2007-12-31$1.08Bn/a2010-02-22, From 2007-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Eli Lilly & Co (LLY)2025-12-31$7.84B+55.0%
Merck & Co., Inc. (MRK)2025-12-31$4.11B+21.9%
Pfizer Inc (PFE)2025-12-31$2.63B-9.6%
AbbVie Inc. (ABBV)2025-12-31$1.21B+24.6%
Bristol Myers Squibb Co (BMY)2025-12-31$1.31B+5.0%
Johnson & Johnson (JNJ)2025-12-28$4.83B+9.2%
Abbott Laboratories (ABT)2025-12-31$2.17B-1.6%
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$501.00M+0.6%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$898.40M+18.9%

Compare LLY, MRK, PFE, ABBV side by side · Screen every company in Pharmaceutical Preparations ↗